Blade therapeutics autotaxin
WebNov 8, 2024 · Blade expects to advance a differentiated pipeline of oral, small-molecule therapies that include a noncompetitive autotaxin inhibitor and inhibitors of dimeric calpains designed for potential ... WebLandos Biopharma is a clinical stage biopharmaceutical company focused on the development of first-in-class, oral therapeutics for patients with autoimmune disease. …
Blade therapeutics autotaxin
Did you know?
WebJun 13, 2024 · Blade expects to advance a differentiated pipeline of oral, small-molecule therapies that include a non-competitive autotaxin inhibitor and inhibitors of dimeric calpains designed for the ... WebSep 4, 2024 · Cudetaxestat (BLD-0409), which is Blade's lead investigational medicine, is a non-competitive autotaxin inhibitor with direct anti-fibrotic activity and differentiating characteristics that is ...
WebSep 4, 2024 · SAN FRANCISCO, September 04, 2024--Blade Therapeutics, Inc., a clinical-stage biopharmaceutical company developing cutting-edge treatments for debilitating fibrotic and neurodegenerative diseases ... WebApr 4, 2024 · Blade Therapeutics, Inc. today announced receipt of feedback from the FDA regarding the company’s end-of-phase 1 data package for cudetaxestat, an investigational non-competitive autotaxin inhibitor in clinical development for treatment of IPF and other fibrotic diseases.
WebOct 18, 2024 · Blade Therapeutics Contacts Media Relations – Michael Blash [email protected] +1-650-453-0632 Investor Relations – Krishna Gorti, M.D. [email protected] +1-973-570-9438 WebBlade Therapeutics is a discovery stage drug development company. Their mission is to create antifibrotic treatment strategies that address a wide variety of congenital and …
WebJan 3, 2024 · About Blade Therapeutics. ... small-molecule therapies that include a non-competitive autotaxin inhibitor and inhibitors of dimeric calpains designed for potential treatment of lung, liver and ...
WebAccord Healthcare, Inc., the US subsidiary of Intas Pharmaceuticals, is a leading generic pharmaceutical company headquartered in Durham, North Carolina. Through its … reddit chase bank auto loansWebProvides specialty pharmaceutical and biopharmaceutical products, related services and targeted therapy management programs. Includes plans, resources and company … reddit chaotic goodWebMay 10, 2024 · Blade Therapeutics is focused on developing cutting-edge treatments for debilitating, incurable fibrotic and neurodegenerative diseases. The company has deep expertise in novel biological pathways – including autotaxin / LPA and calpain biology – that are foundational to cell- and tissue-damage responses associated with fibrotic and ... reddit chapter 7 bankruptcyreddit chapoWebApr 4, 2024 · Blade Therapeutics, Inc. (“Blade” or “Company”), a biopharmaceutical company focused on developing cutting-edge treatments for debilitating fibrotic and neurodegenerative diseases, today announced receipt of feedback from the FDA regarding the company’s end-of-phase 1 data package for cudetaxestat, an investigational non … reddit chapel hillWebAug 25, 2024 · Blade is advancing a differentiated pipeline of oral, small-molecule therapies that include a non-competitive autotaxin inhibitor and multiple inhibitors of dimeric calpains designed for potential ... knoxbry downs argoWebNov 30, 2024 · Blade Therapeutics Announces Positive Topline Data from Phase 1 Clinical Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development … knoxbridge inn